🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

16 results for “amlodipine” Clear

  1. Amlodipine

    Takeda Pharmaceuticals International AG

    Hypertension

    phase 3 small molecule terminated

    1 trial

  2. Amlodipine

    China SXT Pharmaceuticals

    Essential Hypertension

    phase 3 small molecule active

    1 trial

  3. Amlodipine

    First Tracks Biotherapeutics

    Sleep Apnea Syndrome

    phase 3 small molecule active

    1 trial

  4. Amlodipine

    United Therapeutics Europe Ltd

    Depression

    phase 3 small molecule active

    1 trial

  5. Azilsartan Medoxomil and amlodipine

    Takeda Pharmaceuticals International AG

    Hypertension

    phase 3 small molecule completed

    1 trial

  6. Levamlodipine

    China SXT Pharmaceuticals

    Hypertension

    phase 3 small molecule completed

    1 trial

  7. S-Amlodipine TAB (VAM) 1.25 mg, Amlodipine 2.5 mg

    Zentiva k.s.

    Patients with moderate or severe oedema on a long-term treatment with amlodipine

    phase 2 small molecule active

    1 trial

  8. A randomized, single dose, cross-over bioavailability study comparing the drug-drug interaction between telmisartan tablets, indapamide tablets, and amlodipine tablets when co-administered versus the administration of each product alone in three arms to healthy volunteers under fasting conditions.

    s.r.o.

    high blood pressure

    phase 1 other active

    1 trial

  9. A single-dose, randomized, two-period, two-sequence, crossover comparative bioavailability study on formulations containing ramipril, amlodipine and indapamide in combination product versus Triatec® 10 mg capsules (Sanofi - Produtos Farmacêuticos, Lda., Portugal), containing ramipril, Norvasc® 10 mg, tablets (Upjohn EESV, the Netherlands), containing amlodipine and Natrilix® 2.5 mg film-coated tablets (Les Laboratoires Servier, France), containing indapamide co-administered together as reference in healthy

    Pharma Mar S.A.

    hypertension

    phase 1 other active

    1 trial

  10. Amlodipine Besylate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  11. Amlodipine-benazepril 10 mg-20 mg capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  12. BF-Amlodipine Tablet 10mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  13. Randomized, open-label, replicated single-dose, 4-period, 2-sequence crossover study to assess the comparative bioavailability of test product Amlodipine/Valsartan/Hydrochlorothiazide 10 mg/160 mg/12.5 mg film-coated tablets to reference product Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets in healthy male and female subjects under fasting conditions.

    Pharma Mar S.A.

    not applicable (submitted trial is bioavailability)

    phase 1 other active

    1 trial

  14. Amlodipine besylate

    First Tracks Biotherapeutics

    Hypertension

    approved small molecule active

    1 trial

  15. ROSUVASTATIN AND EZETIMIBE , BEMPEDOIC ACID , ROSUVASTATIN AND EZETIMIBE , ATORVASTATIN AND AMLODIPINE

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus

    approved small molecule active

    1 trial

  16. Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete

    Novo mesto

    Arterial hypertension

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources